Does PERISCOPE provide a new perspective on diabetic treatment?
Steg, Philippe Gabriel; Marre, Michel.
; 299(13): 1603-4, 2008 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-18378632
Pioglitazone for type 2 diabetes mellitus.
Effect of the treatment of Type 2 diabetes mellitus on the development of cognitive impairment and dementia.
Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study.
Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review.
Decreased incidence of gout in diabetic patients using pioglitazone.
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus.
Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus-authors' response.
Pioglitazone utilization, efficacy & safety in Indian type 2 diabetic patients: A systematic review & comparison with European Medicines Agency Assessment Report.
Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings.
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.